Feedback / Questions
CAL101 - Calluna Pharma
https://www.businesswire.com/news/home/20250825768765/en/Calluna-Pharma-Announces-Initiation-of-Phase-2-AURORA-Study-of-CAL101-for-Idiopathic-Pulmonary-Fibrosis
Aug 26, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next